News On Japan

High demand weight-loss drug 'Wegovy' now covered by Japan's health insurance

TOKYO - Danish pharmaceutical giant Novo Nordisk's anti-obesity drug "Wegovy" is now covered by Japan's public health insurance scheme. Doctor's, however, are concerned about the long-term effects of this highly addictive weight-loss treatment, and whether worldwide supply shortages will stop it getting into the hands of people who need it most.

The World Obesity Federation warns that by 2025, one in five adults worldwide may be obese, with a third of them having severe obesity with a BMI over 35.

Wegovy leads to an approximate 10% weight reduction through weekly injections of 2.4 mg, as per research including data from Japan. It's a self-administered injection that works by suppressing appetite and stomach movement, aiding in obesity treatment.

Chiba University Hospital's Dr. Kei Ono highlights the scarcity of such obesity drugs globally, with countries like Germany imposing export bans. In the United States, Wegovy's insurance coverage was approved in 2021, and its sales have more than tripled compared to the same period last year.

Another high-demand drug is "Ozempic," originally a diabetes medication known for its appetite-suppressing effects and used off-label for weight loss. Dr. Walden, an expert in obesity treatment drugs, notes the popularity of Wegovy and Ozempic in their clinic, with many patients seeking weight loss for cosmetic reasons.

However, Dr. Walden also points out that these drugs are not a permanent solution and can lead to dependency. Priority should be given to diabetic patients, and there are concerns about drug shortages due to unprescribed use, similar to what happened in the U.S.

Koichi Nagata, suffering from obesity with a BMI exceeding 42, has struggled to lose weight despite efforts like cycling, diet control, and weight training. Wegovy offers hope for fat burning and metabolic improvement, but concerns about side effects remain.

Japan's Ministry of Health, Labour and Welfare has guidelines against prescribing these drugs for non-medical weight loss. Dr. Ono expresses concerns about potential misuse for diet purposes and the resulting supply shortages, affecting those in genuine need.

Additionally, Dr. Ono warns of potential side effects like nausea and acute pancreatitis, emphasizing the importance of following prescribed dosages and medical guidance.

News On Japan
POPULAR NEWS

Japan’s World Cup campaign ended in the cruelest possible fashion on June 29, as Gabriel Martinelli scored in the fifth minute of stoppage time to give Brazil a 2-1 victory over the Samurai Blue in their knockout match in Houston. Japan had led in the first half and were still level at 1-1 in the final moments, but Martinelli’s late strike sent Brazil into the Round of 16 and eliminated Japan from the tournament.

Strong earthquakes have continued to shake parts of Japan in recent weeks, with 11 temblors measuring lower 5 or above on the Japanese seismic intensity scale recorded across the country since April 2026.

A Kintetsu Railway train derailed inside Kyoto Station on the morning of June 29, forcing partial suspensions on the Kintetsu Kyoto Line for the rest of the day and causing long delays that hit commuters, students and tourists.

A section of stone wall at Hikone Castle, one of Japan’s few surviving original Edo-period castles and a National Treasure whose main keep remains intact more than 400 years after its construction, collapsed after heavy rain caused by Typhoons No. 7 and No. 8, Hikone city officials said.

Japan advanced to the knockout stage of the World Cup after a 1-1 draw with Sweden on June 25, finishing second in Group F and setting up a Round of 32 clash with Brazil in Houston.

MEDIA CHANNELS
         

MORE Business NEWS

Tokyo stocks edged higher on June 29 as investors bought back selected shares after a sharp AI-led selloff, but gains were capped by caution over high technology valuations, Middle East tensions and a weakening yen that fell to its lowest level against the dollar since 1986.

Tokyo stocks fell sharply on June 26 as investors locked in profits from Japan’s record-setting AI-driven rally, with SoftBank Group and chip-related shares leading a broad retreat after reports that OpenAI may delay its initial public offering.

Japanese households held 2,386 trillion yen in financial assets at the end of March, up 7.1% from a year earlier, as rising share prices, wider use of the new NISA investment program and the weaker yen lifted the value of assets held by individuals.

The sale of religious corporations that operate temples and shrines across Japan is drawing growing scrutiny from authorities, who fear the transactions could be used for tax evasion and money laundering, as brokers openly advertise properties and corporate status for tens or even hundreds of millions of yen.

The Nikkei Stock Average fell for a second straight session in Tokyo as investors locked in profits from a rapid rally in artificial intelligence and semiconductor-related shares, briefly sending the benchmark down more than 1,300 yen before bargain hunting helped it recover part of the loss.

Imabari Shipbuilding, Kawasaki Heavy Industries, and Namura Shipbuilding are aiming to resume construction of liquefied natural gas carriers around 2035, as Japan’s shipbuilding industry looks for a path to recovery after losing much of the global market to lower-cost rivals in South Korea and China.

Finance Minister Katayama held online talks with U.S. Treasury Secretary Scott Bessent as the yen approached its weakest level in about 39 years, with the two sides believed to have discussed possible responses, including foreign exchange intervention.

Every year, thousands of people save money by buying through the Japanese auction process. But many do not realize they've paid too much until the vehicle arrives.